Wolverine Trading
SRNE

Wolverine Trading’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Wolverine Trading’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-13,452
Closed -$107K – 6989
2021
Q1 		$108K Sell
13,452
-47,452
-78% -$501K ﹤0.01% 5410
2020
Q4 		$441K Buy
+60,904
New +$489K ﹤0.01% 3310

Other funds holding SRNE

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Wolverine Trading's SRNE Position: Q2 2021 in Review

Wolverine Trading sold out of Sorrento Therapeutics, Inc. (SRNE) in Q2 2021, closing a stake of 13,452 shares — an estimated $107K sold.

Wolverine Trading first reported a position in SRNE in Q4 2020 and held it in 2 quarters. The position peaked at $441K in Q4 2020. 212 funds tracked by Wall St. Rank hold SRNE as of Q2 2021.

  • Wolverine Trading reported no remaining Sorrento Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Wolverine Trading sold 13,452 Sorrento Therapeutics, Inc. shares in Q2 2021, an estimated $107K.
  • Wolverine Trading first reported a position in Sorrento Therapeutics, Inc. in Q4 2020 and held it in 2 quarters.
  • Wolverine Trading's Sorrento Therapeutics, Inc. position peaked at $441K in Q4 2020.
  • 212 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q2 2021.

Based on Wolverine Trading's 13F filing for Q2 2021, filed 6 Aug 2021.